» Articles » PMID: 18953032

Hairpin Ribozyme-antisense RNA Constructs Can Act As Molecular Lassos

Overview
Specialty Biochemistry
Date 2008 Oct 28
PMID 18953032
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

We have developed a novel class of antisense agents, RNA Lassos, which are capable of binding to and circularizing around complementary target RNAs. The RNA Lasso consists of a fixed sequence derived from the hairpin ribozyme and an antisense segment whose size and sequence can be varied to base pair with accessible sites in the target RNA. The ribozyme catalyzes self-processing of the 5'- and 3'-ends of a transcribed Lasso precursor and ligates the processed ends to produce a circular RNA. The circular and linear forms of the self-processed Lasso coexist in an equilibrium that is dependent on both the Lasso sequence and the solution conditions. Lassos form strong, noncovalent complexes with linear target RNAs and form true topological linkages with circular targets. Lasso complexes with linear RNA targets were detected by denaturing gel electrophoresis and were found to be more stable than ordinary RNA duplexes. We show that expression of a fusion mRNA consisting of a sequence from the murine tumor necrosis factor-alpha (TNF-alpha) gene linked to luciferase reporter can be specifically and efficiently blocked by an anti-TNF Lasso. We also show in cell culture experiments that Lassos directed against Fas pre-mRNA were able to induce a change in alternative splicing patterns.

Citing Articles

Synthetic circRNA therapeutics: innovations, strategies, and future horizons.

Cai J, Qiu Z, Cho W, Liu Z, Chen S, Li H MedComm (2020). 2024; 5(11):e720.

PMID: 39525953 PMC: 11550093. DOI: 10.1002/mco2.720.


In Vitro Transcribed RNA-Based Platform Vaccines: Past, Present, and Future.

Perenkov A, Sergeeva A, Vedunova M, Krysko D Vaccines (Basel). 2023; 11(10).

PMID: 37897003 PMC: 10610676. DOI: 10.3390/vaccines11101600.


Circular RNA: Biosynthesis .

Chen X, Lu Y Front Bioeng Biotechnol. 2021; 9:787881.

PMID: 34917603 PMC: 8670002. DOI: 10.3389/fbioe.2021.787881.


RNA circularization strategies in vivo and in vitro.

Petkovic S, Muller S Nucleic Acids Res. 2015; 43(4):2454-65.

PMID: 25662225 PMC: 4344496. DOI: 10.1093/nar/gkv045.

References
1.
Wang S, Kool E . Circular RNA oligonucleotides. Synthesis, nucleic acid binding properties, and a comparison with circular DNAs. Nucleic Acids Res. 1994; 22(12):2326-33. PMC: 523691. DOI: 10.1093/nar/22.12.2326. View

2.
Puttaraju M, Perrotta A, Been M . A circular trans-acting hepatitis delta virus ribozyme. Nucleic Acids Res. 1993; 21(18):4253-8. PMC: 310058. DOI: 10.1093/nar/21.18.4253. View

3.
Semerad C, Maher 3rd L . Exclusion of RNA strands from a purine motif triple helix. Nucleic Acids Res. 1994; 22(24):5321-5. PMC: 332077. DOI: 10.1093/nar/22.24.5321. View

4.
Beaudry D, Perreault J . An efficient strategy for the synthesis of circular RNA molecules. Nucleic Acids Res. 1995; 23(15):3064-6. PMC: 307150. DOI: 10.1093/nar/23.15.3064. View

5.
Kool E . Circular oligonucleotides: new concepts in oligonucleotide design. Annu Rev Biophys Biomol Struct. 1996; 25:1-28. DOI: 10.1146/annurev.bb.25.060196.000245. View